By 30 June 2016 at the latest more than 50 pharmaceutical companies operating in Switzerland had disclosed their payments to providers in the healthcare system for consulting and services on their company websites for the first time. These companies cover most of the pharmaceutical market in Switzerland. The transparency initiative was instigated by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and led to in Switzerland an elaboration of the Pharma-Cooperation Code (PCC) at the same time.
The exchange of experiences between the pharmaceutical industry and doctors is absolutely essential for the research and development of new medicines and improves the quality of treatment for patients. The pharmaceutical industry is aware that the subject of relations with healthcare providers is a sensitive issue. Increased transparency is also required today in relations between pharmaceutical companies, the medical profession, pharmacies, hospitals and research institutions. For this reason, the pharmaceutical industry decided to declare payments on an annual basis and thus reinforce trust in the established practice of collaboration.